​Assistant Professor
​Daniel Parker, M.D.

Professional Picture
Department of Urology
University of Oklahoma College of Medicine 
Urologic Oncology

Medical Education:
University of Oklahoma College of Medicine
Temple University College of Medicine / Fox Chase Cancer Center
Urologic Oncology Fellowship:
University of Oklahoma - Stephenson Cancer Center
Stephenson Cancer Clinic:
800 NE 10th Street, Suite 4300
Oklahoma City, OK, 73104
Office: 405-271-4088
Fax: 405-271-4099

920 Stanton L. Young BLVD,  WP ​2140
Oklahoma City, OK, 73104
Office: 405-271-6900
Fax:  405-271-3118

Daniel C. Parker, M.D., is fellowship-trained in urologic oncology, he has established his medical practice with the Stephenson Cancer Center at the University of Oklahoma Health Sciences Center. Dr. Parker is the first graduate from the Stephenson Cancer Center’s new urologic oncology fellowship program, accredited by the Society of Urologic Oncology.

As a urologic oncologist, Dr. Parker will diagnose and treats cancers of the urinary and male reproductive tract including prostate, bladder, penile, kidney, and testicular.

Dr. Parker completed his urologic oncology fellowship at the Stephenson Cancer Center at the OU Health Sciences Center. He completed a urology and general surgery residency at Temple University Hospital in Philadelphia and served as chief resident in urologic oncology at Fox Chase Cancer Center, part of the Temple Health System in Philadelphia. He earned his medical degree at OU College of Medicine and an undergraduate degree from University of Oklahoma. Dr. Parker has chosen to continue his education with a special academic focus in health services and outcomes research, and he is currently enrolled in a competitive master’s degree program at Harvard T.H. Chan School of Public Health.

The Prostate and Urologic Oncology Program at the Stephenson Cancer Center is made up of six fellowship-trained urologic oncologists, the largest group of such physicians in the state. Their team leads the state in prostate and urologic cancer therapies, offering unique services such as minimally invasive surgery, MRI-fusion guided prostate biopsies, and focal therapy for prostate cancer (HIFU).

Dr. Parker has a focus on academic medicine and clinical research, having already authored 11 peer-reviewed publications and five book chapters.